• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钆塞酸二钠增强磁共振动态成像在评估慢性乙型肝炎患者肝纤维化中的应用。

Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.

机构信息

Department of Radiology and Medical Imaging, National Taiwan University College of Medicine and Hospital, No. 7 Chung-Shan S. Rd, Taipei, Taiwan.

出版信息

Eur Radiol. 2012 Jan;22(1):171-80. doi: 10.1007/s00330-011-2249-5. Epub 2011 Aug 31.

DOI:10.1007/s00330-011-2249-5
PMID:21879400
Abstract

OBJECTIVES

To develop a non-invasive MRI method for evaluation of liver fibrosis, with histological analysis as the reference standard.

METHODS

The study protocol was approved by the Institutional Review Board for Human Studies of our hospital, and written informed consent was obtained from all subjects. Seventy-nine subjects who received dynamic contrast-enhanced MRI (DCE-MRI) with Gd-EOB-DTPA were divided into three subgroups according to Metavir score: no fibrosis (n = 30), mild fibrosis (n = 34), and advanced fibrosis (n = 15). The DCE-MRI parameters were measured using two models: (1) dual-input single-compartment model for arterial blood flow (F (a)), portal venous blood flow, total liver blood flow, arterial fraction (ART), distribution volume, and mean transit time; and (2) curve analysis model for Peak, Slope, and AUC. Statistical analysis was performed with Student's t-test and the nonparametric Kruskal-Wallis test.

RESULTS

Slope and AUC were two best perfusion parameters to predict the severity of liver fibrosis (>F2 vs. ≦F2). Four significantly different variables were found between non-fibrotic versus mild-fibrotic subgroups: F (a), ART, Slope, and AUC; the best predictor for mild fibrosis was F (a) (AUROC:0.701).

CONCLUSIONS

DCE-MRI with Gd-EOB-DTPA is a noninvasive imaging, by which multiple perfusion parameters can be measured to evaluate the severity of liver fibrosis.

摘要

目的

开发一种评估肝纤维化的非侵入性 MRI 方法,以组织学分析作为参考标准。

方法

本研究方案获得了我院人体研究伦理委员会的批准,并获得了所有受试者的书面知情同意。79 例接受钆塞酸二钠(Gd-EOB-DTPA)动态对比增强 MRI(DCE-MRI)的患者根据 Metavir 评分分为三组:无纤维化(n=30)、轻度纤维化(n=34)和进展性纤维化(n=15)。使用两种模型测量 DCE-MRI 参数:(1)双输入单室模型用于动脉血流(F(a))、门静脉血流、总肝血流、动脉分数(ART)、分布容积和平均通过时间;(2)曲线分析模型用于峰值、斜率和 AUC。使用 Student's t 检验和非参数 Kruskal-Wallis 检验进行统计分析。

结果

斜率和 AUC 是预测肝纤维化严重程度(>F2 与 ≦F2)的两个最佳灌注参数。在无纤维化与轻度纤维化亚组之间发现了四个显著不同的变量:F(a)、ART、斜率和 AUC;预测轻度纤维化的最佳指标是 F(a)(AUROC:0.701)。

结论

Gd-EOB-DTPA 的 DCE-MRI 是一种非侵入性成像方法,可通过测量多个灌注参数来评估肝纤维化的严重程度。

相似文献

1
Dynamic contrast-enhanced magnetic resonance imaging with Gd-EOB-DTPA for the evaluation of liver fibrosis in chronic hepatitis patients.钆塞酸二钠增强磁共振动态成像在评估慢性乙型肝炎患者肝纤维化中的应用。
Eur Radiol. 2012 Jan;22(1):171-80. doi: 10.1007/s00330-011-2249-5. Epub 2011 Aug 31.
2
Hepatic necro-inflammation and elevated liver enzymes: evaluation with MRI perfusion imaging with gadoxetic acid in chronic hepatitis patients.肝脏坏死性炎症和肝酶升高:慢性肝炎患者应用钆塞酸二钠 MRI 灌注成像评估。
Clin Radiol. 2014 May;69(5):473-80. doi: 10.1016/j.crad.2013.12.003. Epub 2014 Feb 18.
3
Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.磁共振弥散加权成像与钆塞酸二钠增强磁共振动态成像对原发性硬化性胆管炎患者肝纤维化的检测及分期的前瞻性比较。
Eur Radiol. 2019 Feb;29(2):818-828. doi: 10.1007/s00330-018-5614-9. Epub 2018 Jul 16.
4
Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging--initial experience.晚期肝纤维化:三维全肝灌注磁共振成像诊断——初步经验
Radiology. 2008 Mar;246(3):926-34. doi: 10.1148/radiol.2463070077. Epub 2008 Jan 14.
5
Noninvasive Assessment of Liver Fibrosis in Patients with Chronic Hepatitis B or C by Contrast-Enhanced Magnetic Resonance Imaging.慢性乙型或丙型肝炎患者的肝纤维化无创评估:对比增强磁共振成像。
Can J Gastroenterol Hepatol. 2019 Apr 1;2019:3024630. doi: 10.1155/2019/3024630. eCollection 2019.
6
Quantitative assessment of hepatic fibrosis in chronic hepatitis B and C: T1 mapping on Gd-EOB-DTPA-enhanced liver magnetic resonance imaging.慢性乙型和丙型肝炎肝纤维化的定量评估:钆塞酸二钠增强肝脏磁共振 T1 mapping 成像。
World J Gastroenterol. 2018 May 14;24(18):2024-2035. doi: 10.3748/wjg.v24.i18.2024.
7
Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.钆塞酸二钠动态对比增强磁共振成像用于评估四氯化碳诱导的大鼠肝纤维化
PLoS One. 2015 Jun 15;10(6):e0129621. doi: 10.1371/journal.pone.0129621. eCollection 2015.
8
Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage.使用动态钆塞酸二钠增强MRI计算的细胞内摄取率对肝纤维化分期的诊断准确性。
J Magn Reson Imaging. 2017 Apr;45(4):1177-1185. doi: 10.1002/jmri.25431. Epub 2016 Aug 16.
9
Dynamic contrast-enhanced MRI with Gd-EOB-DTPA for the quantitative assessment of early-stage liver fibrosis induced by carbon tetrachloride in rabbits.钆塞酸二钠增强磁共振动态成像在兔四氯化碳诱导早期肝纤维化定量评估中的应用。
Magn Reson Imaging. 2020 Jul;70:57-63. doi: 10.1016/j.mri.2020.04.010. Epub 2020 Apr 20.
10
Noninvasive Assessment of Advanced Fibrosis Based on Hepatic Volume in Patients with Nonalcoholic Fatty Liver Disease.基于肝脏体积的非酒精性脂肪性肝病患者肝纤维化程度的无创评估。
Gut Liver. 2017 Sep 15;11(5):674-683. doi: 10.5009/gnl16440.

引用本文的文献

1
Gadoxetic acid-enhanced magnetic resonance imaging in the assessment of hepatic sinusoidal obstruction syndrome in a mouse model.钆塞酸二钠增强磁共振成像在小鼠模型肝窦阻塞综合征评估中的应用
World J Hepatol. 2024 Aug 27;16(8):1167-1176. doi: 10.4254/wjh.v16.i8.1167.
2
Advances in Noninvasive Molecular Imaging Probes for Liver Fibrosis Diagnosis.用于肝纤维化诊断的非侵入性分子成像探针的进展
Biomater Res. 2024 Jul 1;28:0042. doi: 10.34133/bmr.0042. eCollection 2024.
3
Intravoxel incoherent motion assessment of liver fibrosis staging in MASLD.

本文引用的文献

1
Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.肝硬化大鼠肝脏:转运体活性和胆小管形态变化的参考——钆塞酸增强磁共振成像。
Radiology. 2010 Sep;256(3):767-73. doi: 10.1148/radiol.10092065. Epub 2010 Jul 27.
2
Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.肝细胞癌:钆塞酸增强磁共振成像的信号强度-与分子转运体和组织病理学特征的相关性。
Radiology. 2010 Sep;256(3):817-26. doi: 10.1148/radiol.10092214. Epub 2010 Jul 27.
3
Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT.
磁共振弹性成像评估 MASLD 肝纤维化分期的体素内不相干运动。
Abdom Radiol (NY). 2024 May;49(5):1411-1418. doi: 10.1007/s00261-024-04207-w. Epub 2024 Mar 10.
4
Role of Functional MRI in Liver SBRT: Current Use and Future Directions.功能磁共振成像在肝脏立体定向放射治疗中的作用:当前应用与未来方向
Cancers (Basel). 2022 Nov 28;14(23):5860. doi: 10.3390/cancers14235860.
5
Quantitative Evaluation of Liver Fibrosis on T1 Relaxometry in Comparison with Fibroscan.与Fibroscan相比,基于T1弛豫测量法对肝纤维化的定量评估
Taehan Yongsang Uihakhoe Chi. 2020 Mar;81(2):365-378. doi: 10.3348/jksr.2020.81.2.365. Epub 2020 Feb 18.
6
Magnetic Resonance Imaging of Liver Fibrosis, Fat, and Iron.肝脏纤维化、脂肪和铁的磁共振成像。
Radiol Clin North Am. 2022 Sep;60(5):705-716. doi: 10.1016/j.rcl.2022.04.003. Epub 2022 Jul 15.
7
Evaluation of Rabbits Liver Fibrosis Using Gd-DTPA-BMA of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.使用钆喷酸葡胺-丁二酸单甲酰胺(Gd-DTPA-BMA)的动态对比增强磁共振成像评估兔肝纤维化
Evid Based Complement Alternat Med. 2021 Sep 17;2021:2791142. doi: 10.1155/2021/2791142. eCollection 2021.
8
Magnetic resonance quantitative susceptibility mapping in the evaluation of hepatic fibrosis in chronic liver disease: a feasibility study.磁共振定量磁化率成像在慢性肝病肝纤维化评估中的应用:一项可行性研究
Quant Imaging Med Surg. 2021 Apr;11(4):1170-1183. doi: 10.21037/qims-20-720.
9
Quantitative T2 mapping of rats with chronic hepatitis.慢性肝炎大鼠的定量T2映射
Exp Ther Med. 2021 Mar;21(3):225. doi: 10.3892/etm.2021.9656. Epub 2021 Jan 18.
10
Evaluation of liver function using liver parenchyma, spleen and portal vein signal intensities during the hepatobiliary phase in Gd-EOB-D TPA-enhanced MRI.使用钆塞酸二钠增强 MRI 肝胆期肝实质、脾脏和门静脉信号强度评估肝功能。
BMC Med Imaging. 2020 Oct 20;20(1):119. doi: 10.1186/s12880-020-00519-7.
慢性丙型肝炎病毒感染中的肝纤维化:用灌注 CT 区分最小纤维化和中间纤维化。
Radiology. 2010 Jul;256(1):135-42. doi: 10.1148/radiol.10091295.
4
Reduced mortality rates following elective percutaneous liver biopsies.择期经皮肝脏活检术后死亡率降低。
Gastroenterology. 2010 Oct;139(4):1230-7. doi: 10.1053/j.gastro.2010.06.015. Epub 2010 Jun 12.
5
Nonalcoholic fatty liver disease: US-based acoustic radiation force impulse elastography.非酒精性脂肪性肝病:基于美国的声辐射力脉冲弹性成像技术。
Radiology. 2010 Aug;256(2):640-7. doi: 10.1148/radiol.10091662. Epub 2010 Jun 7.
6
Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid-enhanced MR imaging--correlation with expression of sinusoidal and canalicular transporters and bile accumulation.肝细胞癌:钆塞酸增强磁共振成像的肝细胞选择性增强 - 与窦状隙和胆小管转运体的表达和胆汁积聚的相关性。
Radiology. 2010 Jun;255(3):824-33. doi: 10.1148/radiol.10091557.
7
Added value of gadoxetic acid-enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma.钆塞酸增强肝胆期磁共振成像在肝细胞癌诊断中的应用价值。
Radiology. 2010 May;255(2):459-66. doi: 10.1148/radiol.10091388.
8
Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial.HALT-C 试验中晚期慢性肝病患者经皮肝活检的并发症发生率。
Clin Gastroenterol Hepatol. 2010 Oct;8(10):877-83. doi: 10.1016/j.cgh.2010.03.025. Epub 2010 Apr 1.
9
Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.检测和描述肝脏局灶性病变:一项日本 III 期、多中心的钆塞酸二钠增强磁共振成像与增强计算机断层扫描对比研究,主要针对肝细胞癌和慢性肝病患者。
Invest Radiol. 2010 Mar;45(3):133-41. doi: 10.1097/RLI.0b013e3181caea5b.
10
Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.钆塞酸增强磁共振成像在鉴别 < 或 = 2cm 直径的小肝癌和动脉期增强假性病灶中的应用:特别强调肝胆期成像。
Invest Radiol. 2010 Feb;45(2):96-103. doi: 10.1097/RLI.0b013e3181c5faf7.